Nanomedicine Market to Reach Valuation of USD 288.7 Billion by 2028 - Increasing Demand for Nanomedicine Market for Drug Delivery, Advantages of Nanomedicine in Various Healthcare Applications, and Growth in Need for Safe and Cost-Effective Therapies to Drive the Market Growth
From the period of 2022 to 2028, the Global Nanomedicine Market is expected to reach USD 288.7 Billion in terms of revenue, growing at a Compound Annual Growth Rate (CAGR) of 8.9%.
Nanomaterials have unique physicochemical features that distinguish them from their bulk chemical counterparts because of their small size. These characteristics broaden the range of possibilities for medication development. The nano formulation's physicochemical features, which can modify pharmacokinetics including absorption, distribution, elimination, and metabolism, have the ability to more readily traverse biological barriers, hazardous qualities, and persistence in the environment and human body. Top-down and bottom-up techniques for nanoparticle fabrication are used in pharmaceutical manufacturing. The top-down process involves mechanical or chemical energy breaking down a large object into smaller bits. The bottom-up process, on the other hand, begins with atomic or molecular species, allowing precursor particles to grow in size through a chemical reaction. Nanomedicine Market growth is fueled by new revolutionary drug delivery technologies, the benefits of Nanomedicine in numerous healthcare applications, and the growing demand for safe and cost-effective therapeutics.
Key Highlights from the Report
- On the basis of Modality, the market is segmented into Diagnostics and Treatment. Because of technological advancements in nanomedicines, increased adoption of nanomedicines, rising incidence rates of chronic diseases, and an increase in the number of advanced & effective product launches, the treatment segment was the largest contributor to the global market in 2021 and is expected to remain dominant during the forecast period.
- On the basis of Indication, the market is segmented into Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology, and Others. Because of the increased prevalence of cancer worldwide, the oncological disease segment is expected to grow rapidly in the coming years. In comparison to current therapies, Nanomedicine provides sensitive cancer detection and improved therapeutic efficacy with much fewer adverse effects. The segment will grow as a result of the widespread use of Nanomedicine in oncology.
- Asia Pacific is the fastest regional segment in terms of growth. Due to a large aging population and high prevalence of cancer and cardiovascular disorders, Asia Pacific is predicted to be the fastest-growing market. The Asia Pacific market is expanding due to an increase in research funds and an increase in demand for life-threatening diseases. One element driving market expansion in the Asia-Pacific region is the aging population. China leads the market in this area, owing to the rising incidence of cancer and cardiovascular illnesses, which is fueling market expansion. Japan is thought to be the period's most appealing location.
Increasing the Acquisition of Nanomedicine Across Various Wide Ranges of Applications
Growing government backing and money, as well as an increasing need for a few medicines, are driving the market's rise throughout time. Furthermore, the growth of the Nano-medicine market is influenced by medical research and development in the creation of innovative medications for disorders. Furthermore, increasing applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems, an increase in the number of cancer and cardiovascular diseases, increasing public and private investments in Nanomedicine research, and advancements in biodegradable nanoparticles are all driving the Nanomedicine Market forward.
Unfavorable Approval Processes the Possibility for Unintended Risks During Therapies, and the High Cost of Treatment Using Nanomedicine is Hindering the Global Nanomedicine Market growth
Making nanoparticles biocompatible is one of the most difficult issues for their usage in medicine. Nano capsules have demonstrated outstanding effectiveness in medication delivery in chemotherapy. Nanomedicine allows previously unattainable precision in both diagnostics and therapies. The Nanomedicine Market is likely to benefit from pipeline treatments being developed to target malignant tumors.
Over the projection period, North America is expected to have tremendous growth. Because of massive government spending in Nanomedicine research in the United States, the North American Nanomedicine industry is expected to lead the worldwide Nanomedicine Market throughout the projected period. The increased availability of patented Nano-medicine products is credited with the region's growth. Because of significant government funding in market research, the United States is leading the region in Nanomedicine. Nanomedicine is easily acquired in this region due to its sophisticated healthcare system and high cancer incidence.
The Nanomedicine is segmented as follows:
Browse market data Tables and Figures
Pages and in-depth TOC on "Nanomedicine Market Size, Share & Trends Analysis Report by Modality (Diagnostics, Treatment), by Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine), by Indication (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)"
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Vantage Market Research is a reputed company committed to providing high quality data and market research services. The company provides quantified B2B high quality research on more than 20,000 emerging markets. The company offers detailed reports on multiple industries including chemical materials and energy, food and beverages, healthcare, technology, etc. The company comprises over 125 analysts and consultants, adding more than 1,100 market research reports to its vast database every year. The company’s clientele base spans across 70% of the Global Fortune 500 companies.